ClinicalTrials.Veeva

Menu

Nerve Growth Factor in Chronic Pancreatitis

Virginia Commonwealth University (VCU) logo

Virginia Commonwealth University (VCU)

Status

Completed

Conditions

Chronic Pancreatitis

Study type

Observational

Funder types

Other

Identifiers

NCT01255917
HM11033

Details and patient eligibility

About

This study is to understand the role of nerve growth factor(NGF) and other cytokines in the pancreatic fluid of patients with chronic pancreatitis.

Hypothesis:

  1. Pain does not correlate with changes in the PD morphology suggesting that pain in CP is not only a mechanical problem
  2. Pain in CP correlates better with the levels of NGF in the pancreatic juice. NGF is variably expressed in different morphological stages of CP and regulates the sensitivity of the peptidergic nociceptors and is upregulated in pancreatic inflammation.

Enrollment

38 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with established CP and none of the exclusion criteria mention below.

Exclusion criteria

  • Failure to obtain consent.
  • Any comorbid condition with expected survival < 1 year.
  • Patients with pacemaker, implanted metallic prosthesis or other contraindications to do MRCP.
  • Patients < 18 years of age at time of consent

Trial design

38 participants in 1 patient group

Chronic pancreatitis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems